Michael D Wyatt

14PUBLICATIONS
27CO-AUTHORS
Molecular targetsBiologically active moleculesNeurology and neuromuscular diseasesImmunogenetics (incl. genetic immunology)Basic pharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 01, 2026
Abbapolin inhibitors of the PLK1 PBD as Prostate Cancer Therapeutics, in vivo activity and synergy with androgen therapy.

|May 16, 2025
Structural regulation of PLK1 activity: implications for cell cycle function and drug discovery.

Danda Chapagai, Klaus Strebhardt, Michael D Wyatt

|Jan 24, 2025
Semi-Synthesis of Dimeric Cannabidiol Derivatives and Evaluation of their Affinity at Neurological Targets.

Zachary Stryker, Jorge I Castillo-Arellano, Stephen J Cutler

|Jun 19, 2024
AI-based mining of biomedical literature: Applications for drug repurposing for the treatment of dementia.

Aliaksandra Sikirzhytskaya, Ilya Tyagin, S Scott Sutton

|May 15, 2024
Synthesis and Monoamine Oxidase Inhibitory Activity of Halogenated Flavones.

Jorge I Castillo-Arellano, Zachary Stryker, Michael D Wyatt

|Apr 22, 2024
Collateral damage of NUDT15 deficiency in cancer provides a cancer pharmacogenetic therapeutic window with thiopurines.

Jacob C Massey, Joseph Magagnoli, S Scott Sutton

Pageof 3

Frequent Collaborators

4 joint publications

Campbell McInnes

3 joint publications

S Scott Sutton

3 joint publications

Danda Chapagai

2 joint publications

Ilya Tyagin